Neil Cataldi from Blueprint Capital discusses his investment thesis for Sanara Medtech (SMTI). Sanara is growing quickly, and Neil thinks continued growth in their product portfolio and hospitals they are approved to sell in will drive continued accelerated growth and long term compounding. Chapters 0:00 Intro 1:00 Sanara overview 5:30 How is Sanara increasing their hospital reach? 14:25 Discussing management 21:10 Related party risks 33:20 Breaking down SMTI's growth 42:45 Sanara's telehealth ambitions 1:01:10 Closing thoughts

Yet Another Value Podcast

Neil Cataldi from Blueprint on Sanara Medtech $SMTI

Yet Another Value Podcast is a new podcast from Andrew Walker, the founder of yetanothervalueblog.com/. We interview top investors and dive deep into stocks and companies they are currently working on and investing in. While nothing on this channel is investing advice and everyone should do their own diligence, our goal is to frequently feature edgy and actionable value and/or event driven ideas.
Please see our legal and disclaimer at: https://yetanothervalueblog.substack.com/p/legal-and-disclaimer